Luwen Mu

1.1k total citations
23 papers, 652 citations indexed

About

Luwen Mu is a scholar working on Hepatology, Oncology and Surgery. According to data from OpenAlex, Luwen Mu has authored 23 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 10 papers in Oncology and 6 papers in Surgery. Recurrent topics in Luwen Mu's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Luwen Mu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Luwen Mu collaborates with scholars based in China and United States. Luwen Mu's co-authors include Ning Lyu, Ming Zhao, Qiankun Xie, Shaolong Li, Haijing Deng, Yanan Kong, Jibin Li, Youen Lin, Peihong Wu and Tao Pan and has published in prestigious journals such as Journal of Hepatology, Annals of Oncology and European Journal of Pharmacology.

In The Last Decade

Luwen Mu

23 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luwen Mu China	13	402	228	168	146	143	23	652
Diyang Xie China	8	436 1.1×	150 0.7×	149 0.9×	113 0.8×	109 0.8×	10	632
Fabrício Henrique Pereira De Souza United States	6	648 1.6×	218 1.0×	225 1.3×	195 1.3×	112 0.8×	8	950
Yong Le China	10	464 1.2×	131 0.6×	189 1.1×	216 1.5×	129 0.9×	11	652
Francesca Benevento Italy	11	299 0.7×	141 0.6×	93 0.6×	102 0.7×	215 1.5×	19	699
A. Baldan Italy	7	647 1.6×	137 0.6×	162 1.0×	167 1.1×	121 0.8×	10	862
Chiara Cristofori Italy	6	387 1.0×	107 0.5×	148 0.9×	150 1.0×	83 0.6×	14	547
Yosuke Tsuruga Japan	13	254 0.6×	168 0.7×	225 1.3×	27 0.2×	130 0.9×	43	516
Giulia Orsi Italy	12	89 0.2×	220 1.0×	115 0.7×	55 0.4×	148 1.0×	34	514
Menno T. de Bruijn Netherlands	12	112 0.3×	216 0.9×	169 1.0×	52 0.4×	60 0.4×	18	549
Fatiha Merabtene France	11	77 0.2×	189 0.8×	184 1.1×	62 0.4×	86 0.6×	20	509

Countries citing papers authored by Luwen Mu

Since Specialization

Citations

This map shows the geographic impact of Luwen Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luwen Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luwen Mu more than expected).

Fields of papers citing papers by Luwen Mu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luwen Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luwen Mu. The network helps show where Luwen Mu may publish in the future.

Co-authorship network of co-authors of Luwen Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Luwen Mu. A scholar is included among the top collaborators of Luwen Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luwen Mu. Luwen Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mo, Xiaoyan, Qifeng Chen, Wenbo Guo, et al.. (2025). Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus. Hepatology International. 19(3). 560–575. 2 indexed citations

Chang, Boyang, et al.. (2024). Clinical outcomes of modified transarterial chemoembolization vs. drug-eluting bead transarterial chemoembolization as initial treatment for single hepatocellular carcinoma: a propensity score matching analysis. Annals of Medicine. 56(1). 2423787–2423787. 1 indexed citations

Li, Guohong, et al.. (2023). TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm). Technology in Cancer Research & Treatment. 22. 2223942208–2223942208. 12 indexed citations

Wang, Haofan, Yitao Mao, Xiaojun Hu, et al.. (2022). Prediction of effective percutaneous transhepatic biliary drainage in patients with hepatocellular carcinoma: A multi-central retrospective study. Liver Research. 6(4). 269–275. 1 indexed citations

Zhong, Zhihui, et al.. (2021). The Clinical Value of Computed Tomography (CT)-Guided 125I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy. Cancer Management and Research. Volume 13. 5297–5307. 4 indexed citations

Mu, Luwen, Jing Zhou, Wenjie Tang, et al.. (2021). Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma. Cancer Immunology Immunotherapy. 71(1). 25–38. 21 indexed citations

Sun, Xuqi, et al.. (2020). Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification. Cancer Imaging. 20(1). 42–42. 5 indexed citations

Lyu, Ning, Yanan Kong, Xiaoxian Li, et al.. (2020). Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study. Frontiers in Oncology. 10. 580241–580241. 47 indexed citations

Deng, Haijing, Anna Kan, Ning Lyu, et al.. (2020). Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma. Liver Cancer. 9(3). 338–357. 128 indexed citations

10.

Pan, Tao, et al.. (2020). Stent placement with iodine-125 seeds strand effectively extends the duration of stent patency and survival in patients with unresectable malignant obstructive jaundice. Scandinavian Journal of Gastroenterology. 55(1). 123–128. 15 indexed citations

11.

Zhao, Ming, Jinhua Huang, Ning Lyu, et al.. (2019). Local Thermal Ablation Reboots the Response in Advanced Hepatocellular Carcinoma with Stable or Atypical Progressive Diseases During Anti-PD-1 Therapy. Annals of Oncology. 30. xi45–xi45. 5 indexed citations

12.

Pan, Tao, Qiang Xie, Yanyang Zhang, et al.. (2019). Chiral ruthenium(II) complex Δ-[Ru(bpy)2(o-FMPIP)] (bpy = bipyridine, o-FMPIP = 2-(2′-trifluoromethyphenyl) imidazo[4,5-f][1,10]phenanthroline) as potential apoptosis inducer via DNA damage. European Journal of Pharmacology. 853. 49–55. 4 indexed citations

13.

Lyu, Ning, Yanan Kong, Tao Pan, et al.. (2019). Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread. Journal of Vascular and Interventional Radiology. 30(3). 349–357.e2. 23 indexed citations

14.

Guan, Shouhai, Tao Pan, Yanyang Zhang, et al.. (2019). Synthesis, DNA-binding, and antitumor activity of polypyridyl-ruthenium(II) complexes [Ru(L)₂(DClPIP)] (L = bpy, phen; DClPIP = 2-(2,4-dichlorophenyl)-1H-imidazo[4,5-f][1, 10]phenanthroline). Journal of Coordination Chemistry. 72(12). 2050–2064. 4 indexed citations

15.

Mu, Luwen, Tao Pan, Ning Lyu, et al.. (2018). CT-guided percutaneous radiofrequency ablation for lung neoplasms adjacent to the pericardium. Lung Cancer. 122. 25–31. 12 indexed citations

16.

Lyu, Ning, Yanan Kong, Luwen Mu, et al.. (2018). Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma. Journal of Hepatology. 69(1). 60–69. 202 indexed citations

17.

Li, Shaolong, Xue Han, Ning Lyu, et al.. (2018). Mechanism and prognostic value of indoleamine 2,3‐dioxygenase 1 expressed in hepatocellular carcinoma. Cancer Science. 109(12). 3726–3736. 30 indexed citations

18.

Pan, Tao, Luwen Mu, Chun Wu, et al.. (2017). Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study. Journal of Cancer. 8(17). 3506–3513. 26 indexed citations

19.

Xie, Qiankun, Tao Pan, Ning Lyu, et al.. (2016). Programmed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinoma. OncoImmunology. 5(7). e1181252–e1181252. 49 indexed citations

20.

Lv, Ning, Yanan Kong, Luwen Mu, et al.. (2016). Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial. European Radiology. 26(10). 3492–3499. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact